… Our findings, together with a recent study from Brunner et al. (53), indicate that type 2 inflammation, particularly IL-13 production by T cells, is a consistent feature of both NL and PL …
… Our findings were similar to that reported in another study by Tan et al. [3] who compared the gene expressions between two lines of Jingxing yellow chicken breed involving one …
Kindlin-3 (FERMT-3) is a key integrin activating protein belonging to the Kindlin family which includes three members Kindlin-1, 2 and 3. Kindlins can directly bind to various classes of …
Type III collagen binding protein (TIIICBP) was previously described as a platelet membrane protein that recognizes the KOGEOGPK peptide sequence within type III collagen. In order …
The Abl tyrosine kinase inhibitor imatinb is becoming a standard for the treatment of chronic myelogenous leukemia (CML). However, Bcr-Abl gene mutations have been reported …
… The third building is Al Mamourah where PV system3 has 77 modules covering a total area of 126 m 2 with an installed capacity of 215.7 kW p . The modules have a rated power of 300 …
Simple Summary TERT promoter mutations are the most frequent mutations in melanoma, co-occur regularly with BRAF alterations and are associated with a poorer prognosis. …
Upregulation of phosphodiesterase type 4 (PDE4) has been associated with worse prognosis in several cancers. In melanomas harboring NRAS mutations, PDE4 upregulation has …
Background Phosphodiesterase type 4D (PDE4D) breaks down cyclic AMP (cAMP) reducing the signaling of this intracellular second messenger which plays a major role in melanocyte …
Background Altered tumor suppressor p53 and/or CDKN2A as well as Ras genes are frequently found in primary and metastatic melanomas. These alterations were found to be …